LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.

Jennifer Dahan 1, 2 Yann Nouët 1 Grégory Jouvion 3 Florence Levillayer 1 Minou Adib-Conquy 4 Anne-Marie Cassard-Doulcier 5 Ali Tebbi 2 Fany Blanc 6 Lauriane Remy 2 Ju Chen 7 Stefano Cairo 8 Catherine Werts 9 Mustapha Si-Tahar 6 Thierry Tordjmann 10 Marie-Annick Buendia 1 Yu Wei 1, 2
1 Oncogenèse et Virologie Moléculaire
2 PVHB - Pathogenèse des Virus de l'Hépatite B
3 Histopathologie humaine et Modèles animaux
4 Cytokines et Inflammation
5 Faculté de Médecine Paris Sud
6 Défense innée et inflammation
7 UC San Diego - University of California [San Diego]
8 XenTech
9 Biologie et Génétique de la Paroi bactérienne
10 Signalisation calcique et interactions cellulaires dans le foie
Abstract : Four-and-a-half LIM-only protein 2 (FHL2) is an important mediator in many signaling pathways. In this study, we analyzed the functions of FHL2 in nuclear factor κB (NF-κB) signaling in the liver. We show that FHL2 enhanced tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) activity in transcriptional activation of NF-κB targets by stabilizing the protein. TRAF6 is a binding partner of FHL2 and an important component of the Toll-like receptor-NF-κB pathway. Knockdown of FHL2 in 293-hTLR4/MD2-CD14 cells impaired lipopolysaccharide (LPS)-induced NF-κB activity, which regulates expression of inflammatory cytokines. Indeed, FHL2(-/-) macrophages showed significantly reduced production of TNF and interleukin 6 (IL-6) following LPS stimulation. TNF and IL-6 are the key cytokines that prime liver regeneration after hepatic injury. Following partial hepatectomy, FHL2(-/-) mice exhibited diminished induction of TNF and IL-6 and delayed hepatocyte regeneration. In the liver, NF-κB signaling orchestrates inflammatory cross talk between hepatocytes and hepatic immune cells that promote chemical hepatocarcinogenesis. We found that deficiency of FHL2 reduced susceptibility to diethylnitrosamine-induced hepatocarcinogenesis, correlating with the activator function of FHL2 in NF-κB signaling. Our findings demonstrate FHL2 as a positive regulator of NF-κB activity in liver regeneration and carcinogenesis and highlight the importance of FHL2 in both hepatocytes and hepatic immune cells.
Document type :
Journal articles
Complete list of metadatas

Cited literature [43 references]  Display  Hide  Download
https://hal-univ-tours.archives-ouvertes.fr/hal-01118323
Contributor : Anne Lassailly-Bondaz <>
Submitted on : Thursday, April 30, 2015 - 6:16:57 PM
Last modification on : Thursday, November 30, 2017 - 1:15:33 AM
Long-term archiving on : Monday, September 14, 2015 - 4:57:48 PM

File

3299.full.pdf
Publisher files allowed on an open archive

Identifiers

Collections

UNIV-TOURS | PASTEUR

Citation

Jennifer Dahan, Yann Nouët, Grégory Jouvion, Florence Levillayer, Minou Adib-Conquy, et al.. LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.. Molecular and Cellular Biology, American Society for Microbiology, 2013, 33 (16), pp.3299-308. ⟨10.1128/MCB.00105-13⟩. ⟨hal-01118323⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

211

Files downloads

170

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD